What You Must Know About Australian Pharmaceutical Industries Limited’s (ASX:API) Financial Health
Pharmaceutical | January 03, 2017
Small-cap companies such as Australian Pharmaceutical Industries Limited (ASX:API) with its market cap of USD $724 Million, benefit the most from improving economic conditions due to the growth potential, but on the other hand they also are highly prone to a downturn, thus making their financial strength an important factor in filtering out the risky ones. Although API’s low debt-to-equity ratio of 9.6% indicates financial strength, there’s more to it than just one ratio.